Description

HANSEPRAN 100 MG

Indications

HANSEPRAN 100 MG is primarily indicated for the treatment of various psychiatric disorders, including schizophrenia and acute psychotic episodes. It may also be used in the management of severe anxiety and agitation, as well as for the treatment of certain mood disorders. The medication is often prescribed as part of a comprehensive treatment plan that includes psychotherapy and other supportive measures.

Mechanism of Action

HANSEPRAN 100 MG contains the active ingredient sulpiride, which is classified as an atypical antipsychotic. The mechanism of action of sulpiride involves selective antagonism of dopamine D2 receptors in the central nervous system. By blocking these receptors, HANSEPRAN helps to modulate dopaminergic activity, which is often dysregulated in patients with schizophrenia and other psychotic disorders. This action contributes to the reduction of psychotic symptoms such as hallucinations and delusions.

Pharmacological Properties

HANSEPRAN exhibits a unique pharmacological profile, characterized by its ability to selectively target the limbic system while sparing the nigrostriatal pathway. This selectivity minimizes the risk of extrapyramidal side effects commonly associated with traditional antipsychotics. The drug is well-absorbed after oral administration, with peak plasma concentrations typically reached within 3 to 6 hours. It has a half-life of approximately 8 to 12 hours, allowing for once or twice daily dosing in most patients.

Contraindications

HANSEPRAN 100 MG is contraindicated in patients with a known hypersensitivity to sulpiride or any of the excipients contained in the formulation. Additionally, it should not be used in individuals with a history of neuroleptic malignant syndrome, severe renal impairment, or pheochromocytoma. The medication is also contraindicated during pregnancy unless the potential benefits outweigh the risks, as well as during breastfeeding due to the possibility of excretion in breast milk.

Side Effects

Common side effects associated with HANSEPRAN 100 MG include sedation, weight gain, and gastrointestinal disturbances such as nausea and constipation. Other potential side effects may include dizziness, headache, and dry mouth. In rare cases, patients may experience more severe adverse effects, such as tardive dyskinesia, akathisia, or metabolic syndrome. It is essential for patients to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of HANSEPRAN 100 MG for adults is typically 400 to 800 mg per day, divided into two or three doses. The dosage may be adjusted based on the patient’s response and tolerance to the medication. For elderly patients or those with renal impairment, a lower starting dose may be appropriate to minimize the risk of side effects. It is crucial for patients to follow their healthcare provider’s instructions regarding dosage and to not discontinue the medication abruptly without medical advice.

Interactions

HANSEPRAN 100 MG may interact with other medications, potentially altering its effectiveness or increasing the risk of adverse effects. Notably, concurrent use with other central nervous system depressants, such as benzodiazepines or alcohol, may enhance sedative effects. Additionally, medications that affect renal function may influence the clearance of sulpiride, necessitating dosage adjustments. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Before initiating treatment with HANSEPRAN 100 MG, healthcare providers should conduct a thorough assessment of the patient’s medical history, particularly regarding any history of cardiovascular disease, seizures, or liver dysfunction. Regular monitoring of metabolic parameters, including weight, blood glucose, and lipid levels, is recommended, especially in patients with risk factors for metabolic syndrome. Caution is advised when prescribing HANSEPRAN to elderly patients, as they may be more susceptible to adverse effects. Patients should be educated about the signs and symptoms of serious side effects, such as severe allergic reactions or movement disorders, and instructed to seek medical attention if these occur.

Clinical Studies

Clinical studies have demonstrated the efficacy of HANSEPRAN 100 MG in reducing the symptoms of schizophrenia and other psychotic disorders. In double-blind, placebo-controlled trials, patients receiving sulpiride showed significant improvements in psychotic symptoms compared to those receiving placebo. Long-term studies have indicated that HANSEPRAN can maintain symptom control with a manageable side effect profile, making it a valuable option in the treatment of chronic psychiatric conditions. Further research continues to explore the full range of therapeutic applications and the long-term safety of this medication.

Conclusion

HANSEPRAN 100 MG is a well-established medication in the management of psychiatric disorders, particularly schizophrenia and acute psychotic episodes. Its unique mechanism of action and pharmacological properties make it a suitable choice for many patients. However, as with any medication, careful consideration of contraindications, potential side effects, and drug interactions is essential for safe and effective treatment. Regular follow-up and monitoring are crucial to ensure optimal therapeutic outcomes and to address any emerging concerns during the course of treatment.